當(dāng)心血管疾病（心臟病或中風(fēng)）確診后，醫(yī)生會提供治療建議，但病人的決定是至關(guān)重要的。美國心臟協(xié)會（AHA）與 以病人為中心的成果研究所（PCORI）合作，網(wǎng)絡(luò)征集文章。你可以是患者，社區(qū)志愿者，家庭成員或任何人，只要你有這方面的親身經(jīng)驗。根據(jù)你的情況來闡述患者的治療決策是怎樣做出的，例如：對壽命的影響，對生活質(zhì)量的影響，費用，或其他？同時關(guān)心過程的完整性，時間，等等。。。 “請于2016年6月9日之前將稿件上傳到：https://www.innocentive.com/ar/workspace/challengeDetail?challenge=9933835“ THE CHALLENGE Treatment of heart disease and stroke often requires patients and their families to make many decisions on how to move forward after a cardiac event. Specifically, AHA and PCORI are interested in learning about the “decisional dilemmas” you face – your insights will help guide future research to improve heart health. Based on the input from you and others in the patient and caregiver community, we will identify important concerns and use the perspectives to target research towards what matters most. Despite multiple available treatment options that your physician may describe, you may not always know which option is right/best for you. Tell us about the most difficult decision that you or your family faced when evaluating treatment options for heart disease or stroke. In addition, we would like to understand more about what you considered most important when making this choice or decision. Please pick your top three choices and tell us why they are important to you and your family: Side effects of the treatment Complexity of treatment plan Difficulty in adhering to a treatment Impact on my quality of life Potential to prolong my life Whether the best option for me is selected based on research of people similar to me (personal characteristics such as my age, race and gender) Whether my family history and genetic makeup would influence the effectiveness of a given option Whether a trusted source recommended a specific option The financial impact of the options for me and my family Other:________ Any submission should address the following Submission Requirements: The submission can be from anyone (patient, caregiver, family member, or other)   [更多]

求最新西普樂（乳酸環(huán)丙沙星氯化鈉注射液）說明書   [更多]

頭孢地尼顆粒JX20100254的具體標(biāo)準(zhǔn)，價格可商議   [更多]

1、以顆粒劑為主（我們主要是想保住顆粒劑生產(chǎn)線），片劑、膠囊劑還有小容量注射劑，也接受。 2、要求直接提供賣家信息，不接受中介。 3、藥智技術(shù)轉(zhuǎn)讓數(shù)據(jù)庫里面沒有的信息，若有我會截圖證明。 感謝藥智戰(zhàn)友！   [更多]

防粘連產(chǎn)品屬于三類醫(yī)療器械，現(xiàn)需行業(yè)終端銷售數(shù)據(jù)、市場分布等信息。價格另議。   [更多]

求助“Acetylsalicylic acid ”《 EP8.8 》的藥典標(biāo)準(zhǔn)一份   [更多]

以1000元求購一個華招醫(yī)藥網(wǎng)會員賬號，保證在1年之內(nèi)可進(jìn)行中標(biāo)數(shù)據(jù)信息的有效查詢。 PS:請不要用賬號密碼直接投標(biāo)，請先溝通之后再給賬號密碼   [更多]

具體要求： 以1000元求購一個易邁得會員賬號，保證在1年之內(nèi)可進(jìn)行中標(biāo)數(shù)據(jù)信息的有效查詢。 PS:請不要用賬號密碼直接投標(biāo)，請先溝通之后再給賬號密碼。   [更多]

求購“Ranitidine Hydrochloride”《 BP2015 》的藥典標(biāo)準(zhǔn)一份.   [更多]

需要的是阿立哌唑溶液劑的藥典標(biāo)準(zhǔn)，是溶液劑的藥典標(biāo)準(zhǔn)，?。。。。?！不要原料藥的標(biāo)準(zhǔn)。需查找美國、歐洲、日本的最新版本的藥典，如沒有收錄請附目錄證明。   [更多]